Newbridge Financial Services Group, Inc. Cue Biopharma, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $575 Million
- Q2 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 3,000 shares of CUE stock, worth $2,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000
Previous 3,500
14.29%
Holding current value
$2,490
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CUE
# of Institutions
48Shares Held
17.7MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$5.66 Million1.47% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.77 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$2.65 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$628,0900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA692KShares$574,5030.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $29.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...